top
Search terms
Results 1 - 2 of 2 - ordered by :
Ehjournal

Furthermore, the EMPA-REG OUTCOME trial using the novel antihyperglycaemic agent, empagliflozin,8 a selective sodiumglucose co- transporter inhibitor, significantly reduced cardiovascular mortality; ...

European Heart Journal, ISSUE @ A GLANCE, Thomas F. Lüscher

Date : 07/02/2016
Ehjournal

Furthermore, pressure on publishing, low acceptance rates in prestigious journals, as well as fierce competition for grants have contributed to an increase in scientific misconduct2 and, therefore, ...

European Heart Journal, ISSUE @ A GLANCE, Thomas F. Lüscher

Date : 01/03/2016